Abbott Rapid Diagnostics A/S: Financial statements 2018
CVR: 24204650
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 14,948,878 and a net result of DKK 983,465 compared with DKK 99,340 the year before. That is a decrease of 17.7% compared with the year before. Equity in the 2018 report amounted to DKK 24,591,569. The solvency ratio was 62.3%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 14,948,878
- Profit/Loss
- DKK 983,465
- Equity
- DKK 24,591,569
- Total Assets
- DKK 39,455,976
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 14.9 mio. | 983 t. | 24.6 mio. | 19 |
| 2017 | - | 18.2 mio. | 99 t. | 23.6 mio. | 23 |
| 2016 | - | 18.7 mio. | -330 t. | 23.5 mio. | 21 |
| 2015 | - | 23.4 mio. | 4.1 mio. | 23.8 mio. | 22 |
| 2014 | - | 20 mio. | -2.8 mio. | 19.8 mio. | 27 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of July 1, 2018, Henrik Kjeldsmark Jensen is registered as adm. dir. of Abbott Rapid Diagnostics A/S.
As of June 30, 2018, Brian B. Yoor has left the board of directors of Abbott Rapid Diagnostics A/S.
As of June 30, 2018, Christopher Gustaf Aulin has stepped down as adm. dir. of Abbott Rapid Diagnostics A/S.
Abbott Rapid Diagnostics A/S has published its annual report for 2017. Gross profit came to DKK 18,158,716, and the net result was DKK 99,340.
About Abbott Rapid Diagnostics A/S
Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.